Perry Nicole D 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jun 2, 2021
Insider Transaction Report
Form 4
Perry Nicole D
Vice President - Finance
Transactions
- Exercise/Conversion
Common Stock
2021-06-01$3.76/sh+1,000$3,760→ 5,847 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-01−1,000→ 8,161 totalExercise: $3.76Exp: 2025-07-31→ Common Stock (1,000 underlying) - Sale
Common Stock
2021-06-01$56.40/sh−1,000$56,400→ 4,847 total
Footnotes (2)
- [F1]This is a scheduled exercise from a 10B5-1 trading plan.
- [F2]This option was granted on July 31, 2015 and is fully vested.